Verily, an Alphabet company founded in 2015, operates at the intersection of health data and clinical infrastructure - exactly the kind of environment where security posture can't be an afterthought. The company integrates data science, AI, and clinical expertise into precision health platforms, managing registries with over 750,000 consented participants, powering virtual care for 50,000+ patients, and connecting 63 health systems for clinical trials. That's a sprawling attack surface: protected health information flowing across institutions, research data pipelines, and patient-facing applications all running concurrently.
Verily's flagship platform, Pre, is an AI-native system built to accelerate research and enable data-driven decisions across the healthcare ecosystem. The threat model here spans the standard healthcare stack - PHI exfiltration, supply-chain compromise in clinical integrations, adversarial manipulation of AI pipelines - but also includes regulatory exposure. The team operates across Dallas, California, Boston, Raleigh, and Waterloo, with an interdisciplinary mix of clinicians, informaticists, engineers, data scientists, and regulatory experts working alongside partners like NIH's All of Us Research Program and The Michael J. Fox Foundation.
For security practitioners, the draw is specificity: you're not defending a generic cloud product, you're protecting clinical trial data, patient registries, and AI-driven health tools where the consequences of failure are measured in regulatory action and real patient harm. The engineering culture skews toward cross-disciplinary collaboration, which means security isn't siloed - it's embedded in the data science and clinical workflows that define the company's core output.
